Metabolic Characteristics and Prognostic Model of Acute Coronary Syndrome Complicated With Obstructive Sleep Apnea

Starting soon

Conditions studied: Sleep Disordered Breathing (SDB)

In brief

Obstructive sleep apnea (OSA) significantly increases the risk of cardiovascular events in patients with acute coronary syndrome (ACS), yet the underlying metabolic mechanisms remain unclear. This study aims to analyze the metabolic characteristics of ACS patients with OSA using metabolomics based on a prospective cohort. The study intends to construct an artificial intelligence-based risk stratification model to improve prognosis prediction and facilitate precision medicine for this population.

Key facts

Study ID

NCT07398430

Run by

Beijing Hospital

People needed

1200

Starts

2026-02-01

Expected to finish

2027-12-31

Last updated by the study team

2026-02-09

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-85 years.
• Diagnosed with ACS, including ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina.
• Willing to participate and sign the informed consent form.

You may not qualify if…

• Cardiogenic shock or cardiac arrest.
• Central sleep apnea or other types of sleep disordered breathing.
• Previous or current treatment with continuous positive airway pressure.
• Inability to complete polysomnography or invalid data.
• Malignancy or life expectancy < 1 year.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.